2022
DOI: 10.1016/j.bioactmat.2021.04.036
|View full text |Cite
|
Sign up to set email alerts
|

Novel magnetic silk fibroin scaffolds with delayed degradation for potential long-distance vascular repair

Abstract: Although with the good biological properties, silk fibroin (SF) is immensely restrained in long-distance vascular defect repair due to its relatively fast degradation and inferior mechanical properties. It is necessary to construct a multifunctional composite scaffold based on SF. In this study, a novel magnetic SF scaffold (MSFCs) was prepared by an improved infiltration method. Compared with SF scaffold (SFC), MSFCs were found to have better crystallinity, magnetocaloric properties, and mechanical strength, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

4
5

Authors

Journals

citations
Cited by 30 publications
(17 citation statements)
references
References 63 publications
0
17
0
Order By: Relevance
“…Even in the absence of magnetic fields, doping the scaffolds with MNPs can alter their activity as a drug delivery system. For instance, the addition of MNPs reduced the degradation of silk fibroin scaffolds that have been proposed as multifunctional composite for tissue engineering [239]. In particular, the degradation rate of these sponges was strongly affected by the presence of the MNPs and correlated with the availability of active sites for proteases' binding.…”
Section: Mnps For Scaffold Enrichment and Release Of Drug/cellsmentioning
confidence: 99%
“…Even in the absence of magnetic fields, doping the scaffolds with MNPs can alter their activity as a drug delivery system. For instance, the addition of MNPs reduced the degradation of silk fibroin scaffolds that have been proposed as multifunctional composite for tissue engineering [239]. In particular, the degradation rate of these sponges was strongly affected by the presence of the MNPs and correlated with the availability of active sites for proteases' binding.…”
Section: Mnps For Scaffold Enrichment and Release Of Drug/cellsmentioning
confidence: 99%
“…Due to the high surface area volume ratio, compatible capture and release ability, nanomaterials provide a high collision probability for antibodies and CTCs ( Park et al, 2017 ; Wu C. et al, 2019 ; Shi et al, 2022 ; Yi et al, 2022 ; Liu et al, 2022 ; Liu J. et al, 2021 ), which can help improve the sensitivity and specificity of capture, and have attracted extensive attention in the separation of CTCs ( Wongkaew et al, 2018 ; Wu and Qu, 2015 ; Zhu G. et al, 2021 ; Naskar et al, 2020 ; Chandankere et al, 2020 ). So far, carbon nanotubes (CNTs) ( Cho H. et al, 2018 ; Zhang P. et al, 2019 ; Poudineh et al, 2017 ), graphene oxide (GO) ( Chen et al, 2012 ; Yoon et al, 2013 ; Yu X. et al, 2013 ; Yoon et al, 2016 ), gold nanoparticles (AuNP) ( Park et al, 2017 ), nanocolumns ( Lin et al, 2014 ; Shi et al, 2022 ) and TiO 2 nanofibers ( Zhang et al, 2012 ) have been widely used in affinity group capture methods ( Zhao et al, 2016 ; Cai et al, 2017 ; Wongkaew et al, 2018 ).…”
Section: Microfluidic Technologies For Ctcs Separationmentioning
confidence: 99%
“…Given the above-mentioned unsatisfactory factors and the shortcomings of secondary operations caused by non-degradability, it has always been a goal to seek natural materials with better biocompatibility to construct vascular grafts. Unfortunately, the many properties of natural materials cannot meet the application requirements of vascular grafts, such as mechanical strength [ 85 ], elasticity [ 16 ], and degradation [ 86 , 87 ]. MNPs are believed to effectively improve the performance of vascular grafts and provide more applications in other areas (such as MRI [ 43 ] or nano-modification [ 88 ]).…”
Section: Mnps For Vascular Repairmentioning
confidence: 99%
“…Vascular repair mainly includes three stages: inflammation, neointimal hyperplasia, and vascular remodeling, in which dysfunction at any stage will affect the vascular repair [ 10 , 11 , 12 ]. Due to their unique magnetic responsiveness [ 13 , 14 ], magnetic nanoparticles (MNPs) are considered an effective non-invasive technical means to assist in various stages of vascular repair and have achieved good results in both diagnosis and treatment [ 15 , 16 , 17 ]. For example, MNPs are used as magnetic resonance contrast agents to evaluate and monitor the fate and function of grafts with non-invasive imaging methods [ 18 , 19 , 20 ]; MNPs-labeled vascular endothelial cells (VECs) can be driven to seed at designated sites to accelerate endothelialization [ 16 ]; MNPs are used as a targeted anticoagulant drug carrier reduces thrombus formation [ 21 , 22 ], etc.…”
Section: Introductionmentioning
confidence: 99%